Psoriasis can contribute to erectile dysfunction through several overlapping pathways, including chronic inflammation, blood vessel damage, psychological distress, and side effects from certain treatments. In studies comparing men with psoriasis to healthy controls, ED rates are consistently higher in the psoriasis group. One large survey found that 58% of men with psoriasis had scores indicating ED, compared to 49% of controls, with psoriasis roughly doubling the odds after adjusting for age.
How Inflammation Damages Blood Flow
Psoriasis is not just a skin condition. It drives bodywide inflammation that affects blood vessels throughout the body, including those that supply the penis. Erections depend on blood vessels relaxing and expanding to allow increased blood flow. That relaxation is controlled by a signaling molecule called nitric oxide. In psoriasis, the chronic inflammatory state directly interferes with nitric oxide production and availability.
Here’s the chain of events: inflammatory proteins produced by the overactive immune system (the same ones responsible for skin plaques) activate the lining of blood vessels and shift them into a dysfunctional state. The vessel walls become stiffer, more prone to attracting immune cells, and less responsive to signals telling them to relax. Men with psoriasis have elevated levels of a compound that blocks the enzyme responsible for making nitric oxide, and those levels tend to rise in step with disease severity. The result is reduced blood flow, not just to the skin but to all vascular beds, including penile tissue.
This vascular damage is the same process that leads to atherosclerosis, which is why psoriasis is now recognized as an independent risk factor for heart disease and stroke. ED and cardiovascular disease share the same underlying mechanism: inflamed, stiffened arteries that can’t dilate properly.
Worse Psoriasis, Worse ED
The connection between psoriasis and ED isn’t all-or-nothing. It scales with how severe the skin disease is. A 2025 case-control study found that 80.7% of men with psoriasis had some degree of ED compared to 67.5% of controls, and the psoriasis group was significantly more likely to have moderate or severe ED. After controlling for other variables, higher disease severity scores and older age at psoriasis onset were independent risk factors for ED.
Sexual dysfunction was also more pronounced in patients with moderate to severe psoriasis in studies looking at psychological mediators. This dose-response relationship reinforces that the disease process itself, not just the stress of having a chronic illness, plays a direct role.
Body Image Matters More Than Depression
It would be easy to assume that depression or anxiety explains the higher ED rates, since psoriasis is well known to affect mental health. But the research tells a more specific story. A study examining the psychological pathways found that body image satisfaction was the significant mediator between psoriasis severity and sexual dysfunction. Anxiety, depression, and self-esteem did not independently mediate the relationship once body image was accounted for.
Men with psoriasis reported significantly lower body image satisfaction than controls. Visible plaques, scaling, and flaking, particularly in intimate areas, can make people avoid sexual situations entirely or struggle with arousal when they do engage. Genital psoriasis, which affects a meaningful proportion of patients at some point, compounds this further. The presence of genital lesions was specifically associated with ED in case-control data.
Metabolic Syndrome Compounds the Risk
Psoriasis clusters with other conditions that independently raise ED risk: obesity, high blood pressure, abnormal cholesterol, insulin resistance, and metabolic syndrome. In one study, about a third of men with psoriasis had metabolic syndrome compared to 22% of controls. When researchers separated the psoriasis group into those with and without metabolic syndrome, erectile function scores were significantly worse in the metabolic syndrome subgroup.
This creates a compounding effect. Psoriasis drives inflammation that damages blood vessels. Metabolic syndrome does the same through altered blood lipid profiles, increased atherosclerosis, and reduced penile blood flow. When both are present, the vascular insult is greater than either alone. Multiple regression analysis confirmed that age, metabolic syndrome, depression scores, and psoriasis itself were all independent predictors of erectile function, meaning each one adds its own layer of risk.
Some Psoriasis Medications Can Worsen ED
Certain systemic treatments used for psoriasis have documented sexual side effects, which can make it difficult to untangle the disease from the treatment. Two medications stand out.
- Retinoids (acitretin): Case reports describe ED and loss of morning erections developing within weeks of starting the drug, with symptoms reversing after discontinuation. Depression, which retinoids can also trigger, may play a contributing role.
- Methotrexate: Though the drug’s labeling calls sexual side effects “extremely rare,” multiple case reports document ED and decreased libido appearing within two to three weeks of starting treatment. In each reported case, symptoms resolved within weeks of stopping or switching medications.
Notably, a large population study of over 12,000 men with psoriasis found that the increased risk of sexual dysfunction was not significantly higher in those using systemic drugs compared to those who weren’t. This suggests the disease itself is the primary driver, with medication side effects affecting a smaller subset of patients.
Biologic Therapy Can Improve Erectile Function
If inflammation is a root cause, then treating the inflammation should help. Early data supports this. A pilot study of men with moderate to severe psoriasis who started biologic therapy (drugs that block specific inflammatory proteins like TNF-alpha) found that erectile function scores improved by an average of 9.5 points on a standardized scale over six months. The men started with scores indicating mild ED, and scores improved alongside their skin clearance.
This makes biological sense. Blocking the inflammatory cascade reduces the vascular damage that impairs blood flow. Research on vascular function in psoriasis patients receiving TNF-alpha blockers has shown improvements in resting blood vessel tone, suggesting the endothelial damage is at least partially reversible when inflammation is controlled. The improvement in erectile function likely reflects both better blood vessel health and the psychological benefits of clearer skin and improved body image.
What This Means Practically
If you have psoriasis and are experiencing ED, the two are likely connected. The relationship runs through at least three channels: direct vascular damage from chronic inflammation, body image distress affecting arousal and intimacy, and in some cases, medication side effects. More severe psoriasis carries greater risk.
Addressing ED in the context of psoriasis means looking at the full picture. Aggressively treating the underlying skin disease, especially with biologic therapies for moderate to severe cases, can improve erectile function alongside skin clearance. Screening for metabolic syndrome is important, since treating high blood pressure, cholesterol, and blood sugar independently benefits vascular health. If ED appeared shortly after starting methotrexate or a retinoid, that timing is worth raising with your prescriber, as the effect is typically reversible with a medication change.
Sexual health is an underscreened area in dermatology. Researchers have specifically called for routine assessment of sexual function in psoriasis patients, noting that ED in this population represents both an unmet need and an opportunity to identify broader cardiovascular risk. If your dermatologist hasn’t asked, bring it up yourself.